201 related articles for article (PubMed ID: 33116852)
1. Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications.
Hadjipanteli A; Doolan P; Kyriacou E; Constantinidou A
Cancer Manag Res; 2020; 12():9953-9964. PubMed ID: 33116852
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
Fares J; Kanojia D; Rashidi A; Ahmed AU; Balyasnikova IV; Lesniak MS
Clin Breast Cancer; 2019 Dec; 19(6):383-391. PubMed ID: 31262686
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
5. Management of brain metastases in breast cancer: a review of current practices and emerging treatments.
Mills MN; Figura NB; Arrington JA; Yu HM; Etame AB; Vogelbaum MA; Soliman H; Czerniecki BJ; Forsyth PA; Han HS; Ahmed KA
Breast Cancer Res Treat; 2020 Apr; 180(2):279-300. PubMed ID: 32030570
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatments for breast cancer brain metastasis.
Chen Q; Xiong J; Ma Y; Wei J; Liu C; Zhao Y
Front Oncol; 2022; 12():1086821. PubMed ID: 36686840
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
8. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
[TBL] [Abstract][Full Text] [Related]
9. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
10. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of breast cancer CTCs associated with brain metastasis.
Boral D; Vishnoi M; Liu HN; Yin W; Sprouse ML; Scamardo A; Hong DS; Tan TZ; Thiery JP; Chang JC; Marchetti D
Nat Commun; 2017 Aug; 8(1):196. PubMed ID: 28775303
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
An M; Zang X; Wang J; Kang J; Tan X; Fu B
Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery.
Zheng Y; Geng D; Yu T; Xia W; She D; Liu L; Yin B
Acta Radiol; 2021 Sep; 62(9):1208-1216. PubMed ID: 32910684
[TBL] [Abstract][Full Text] [Related]
14. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Brain Metastasis: A Comprehensive Review.
Raghavendra AS; Ibrahim NK
JCO Oncol Pract; 2024 May; ():OP2300794. PubMed ID: 38748968
[TBL] [Abstract][Full Text] [Related]
16.
Xie N; Tian C; Wu H; Yang X; Liu L; Li J; Xiao H; Gao J; Lu J; Hu X; Cao M; Shui Z; Tang Y; Wang X; Yang J; Hu ZY; Ouyang Q
Ther Adv Med Oncol; 2020; 12():1758835920915305. PubMed ID: 32499836
[TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Schlam I; Gatti-Mays ME
Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
[TBL] [Abstract][Full Text] [Related]
18. Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Mills MN; King W; Soyano A; Pina Y; Czerniecki BJ; Forsyth PA; Soliman H; Han HS; Ahmed KA
J Neurooncol; 2022 Apr; 157(2):249-269. PubMed ID: 35244835
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study.
Deng J; Zhang D; Zhang W; Li J
Int J Gen Med; 2021; 14():8881-8902. PubMed ID: 34866932
[TBL] [Abstract][Full Text] [Related]
20. A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases.
Joe NS; Hodgdon C; Kraemer L; Redmond KJ; Stearns V; Gilkes DM
NPJ Breast Cancer; 2021 Sep; 7(1):121. PubMed ID: 34521857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
